Brought to you by 
Evotec launches Fibrocor, gets funding from MaRS Innovation
17 Jan 2017
Executive Summary
Evotec AG is launching fibrotic disease-focused firm Fibrocor Therapeutics LP, which is concurrently raising $Cdn2.8mm ($2.1mm) from MaRS Innovation.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Financing
- Private Placement
- Spin-Off
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com